BIM
IDIX

BlackRock Investment Management’s IDENIX PHARMACEUTICALS INC IDIX Stock Holding History

BlackRock Investment Management’s Portfolio IDIX Stock Details IDIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-328,762
Closed -$7.92M – 4133
2014
Q2 		$7.92M Buy
328,762
+10,071
+3% +$105K 0.01% 1115
2014
Q1 		$1.92M Buy
318,691
+36,144
+13% +$252K ﹤0.01% 2073
2013
Q4 		$1.69M Sell
282,547
-7,627
-3% -$35.3K ﹤0.01% 2145
2013
Q3 		$1.51M Buy
290,174
+17,439
+6% +$76.4K ﹤0.01% 2159
2013
Q2 		$985K Buy
+272,735
New +$1.12M ﹤0.01% 2361

BlackRock Investment Management's IDIX Position: Q3 2014 in Review

BlackRock Investment Management sold out of IDENIX PHARMACEUTICALS INC (IDIX) in Q3 2014, closing a stake of 328,762 shares — an estimated $7.92M sold.

BlackRock Investment Management first reported a position in IDIX in Q2 2013 and held it in 5 quarters. The position peaked at $7.92M in Q2 2014. 0 funds tracked by Wall St. Rank hold IDIX as of Q3 2014.

  • BlackRock Investment Management reported no remaining IDENIX PHARMACEUTICALS INC position as of Q3 2014 after selling out during the quarter.
  • BlackRock Investment Management sold 328,762 IDENIX PHARMACEUTICALS INC shares in Q3 2014, an estimated $7.92M.
  • BlackRock Investment Management first reported a position in IDENIX PHARMACEUTICALS INC in Q2 2013 and held it in 5 quarters.
  • BlackRock Investment Management's IDENIX PHARMACEUTICALS INC position peaked at $7.92M in Q2 2014.
  • 0 funds tracked by Wall St. Rank held IDENIX PHARMACEUTICALS INC as of Q3 2014.

Based on BlackRock Investment Management's 13F filing for Q3 2014, filed 29 Oct 2014.